Medtronic's Melody Transcatheter Pulmonary Valve Gets FDA Panel Date
This article was originally published in The Gray Sheet
FDA's Circulatory System Devices Panel will review a humanitarian device exemption application for Medtronic's Melody transcatheter pulmonary valve and Ensemble delivery system July 22, according to a July 2 Federal Register notice
You may also be interested in...
Medtronic will enter the high-growth, minimally invasive aortic heart valve market through two acquisitions worth more than $1 billion
Feasibility trial results show Medtronic's Melody transcatheter pulmonary heart valve reduces right ventricular volume by 18% in patients with dysfunctional right ventricular outflow tract conduits
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.